ICM
PMD

Invenomic Capital Management’s Psychemedics Corporation PMD Stock Holding History

Invenomic Capital Management’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-43,560
Closed -$276K – 200
2022
Q2 		$276K Sell
43,560
-92,071
-68% -$590K 0.02% 143
2022
Q1 		$769K Buy
135,631
+9,154
+7% +$64.8K 0.08% 139
2021
Q4 		$878K Buy
126,477
+1,162
+0.9% +$9.29K 0.19% 114
2021
Q3 		$1.06M Buy
125,315
+13,661
+12% +$100K 0.35% 84
2021
Q2 		$777K Sell
111,654
-1,113
-1% -$7.8K 0.19% 91
2021
Q1 		$699K Sell
112,767
-20,846
-16% -$138K 0.16% 94
2020
Q4 		$680K Buy
133,613
+32,529
+32% +$141K 0.17% 85
2020
Q3 		$446K Buy
101,084
+23,020
+29% +$112K 0.25% 98
2020
Q2 		$430K Buy
+78,064
New +$436K 0.32% 94

Other funds holding PMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invenomic Capital Management's PMD Position: Q3 2022 in Review

Invenomic Capital Management sold out of Psychemedics Corporation (PMD) in Q3 2022, closing a stake of 43,560 shares — an estimated $276K sold.

Invenomic Capital Management first reported a position in PMD in Q2 2020 and held it in 9 quarters. The position peaked at $1.06M in Q3 2021. 23 funds tracked by Wall St. Rank hold PMD as of Q3 2022.

  • Invenomic Capital Management reported no remaining Psychemedics Corporation position as of Q3 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 43,560 Psychemedics Corporation shares in Q3 2022, an estimated $276K.
  • Invenomic Capital Management first reported a position in Psychemedics Corporation in Q2 2020 and held it in 9 quarters.
  • Invenomic Capital Management's Psychemedics Corporation position peaked at $1.06M in Q3 2021.
  • 23 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q3 2022.

Based on Invenomic Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.